# Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita

> **NCT00936533** · PHASE2 · UNKNOWN · sponsor: **Uppsala University** · enrollment: 40 (estimated)

## Conditions studied

- Epidermolysis Bullosa Simplex

## Interventions

- **DRUG:** Dysport® (Botulinumtoxin A (Btx A))
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00936533
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00936533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00936533, "Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00936533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*